ArticleAmerican journal of epidemiology2021
Transporting Subgroup Analyses of Randomized Controlled Trials for Planning Implementation of New Interventions.
Article in American journal of epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Demand creation for HIV testing services: A systematic review and meta-analysis.PLoS medicine · 2023Pooled it
- Transporting the effect of the ASSIST school-based smoking prevention intervention to the Smoking, Drinking and Drug Use Among Young People in England Survey (2004-2021): A secondary analysis of a randomized controlled trial.Addiction (Abingdon, England) · 2025Trial
- Regression-based estimation of heterogeneous treatment effects when extending inferences from a randomized trial to a target population.European journal of epidemiology · 2023Trial
- Estimating and Evaluating Counterfactual Prediction Models.Statistics in medicine · 2025Article
- When, why and how are estimated effects transported between populations? A scoping review of studies applying transportability methods.European journal of epidemiology · 2025Article
- Improving efficiency in transporting average treatment effects.Biometrika · 2025Article
- Reliability and validity of intervention characteristic measures for assessing barriers to evidence-based practice use.Translational behavioral medicine · 2024Article
- Estimating Subgroup Effects in Generalizability and Transportability Analyses.American journal of epidemiology · 2024Article
- Quantifying and reducing inequity in average treatment effect estimation.BMC medical research methodology · 2023Article
- Invited Commentary: Conducting and Emulating Trials to Study Effects of Social Interventions.American journal of epidemiology · 2022Article
- Estimating preclinical amyloid positivity: A case study transporting ADNI to ARIC.Alzheimer's & dementia (New York, N. Y.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Subgroup analyses of randomized controlled trials guide resource allocation and implementation of new interventions by identifying groups of individuals who are likely to benefit most from the intervention. Unfortunately, trial populations are rarely representative of the target populations of public health or clinical interest. Unless the relevant differences between trial and target populations are accounted for, subgroup results from trials might not reflect which groups in the target population will benefit most from the intervention. Transportability provides a rigorous framework for applying results derived in potentially highly selected study populations to external target populations. The method requires that researchers measure and adjust for all variables that 1) modify the effect of interest and 2) differ between the target and trial populations. To date, applications of transportability have focused on the external validity of overall study results and understanding within-trial heterogeneity; however, this approach has not yet been used for subgroup analyses of trials. Through an example from the Iniciativa Profilaxis Pre-Exposición (iPrEx) study (multiple countries, 2007-2010) of preexposure prophylaxis for human immunodeficiency virus, we illustrate how transporting subgroup analyses can produce target-specific subgroup effect estimates and numbers needed to treat. This approach could lead to more tailored and accurate guidance for resource allocation and cost-effectiveness analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.